Scholar Rock is a clinical-stage biopharmaceutical company.
51 - 200
π° $205M Post-IPO Equity on 2022-06
Yesterday
51 - 200
Drive talent acquisition strategies as Scholar Rock prepares for significant growth and product launch.
πΊπΈ United States β Remote
π° $205M Post-IPO Equity on 2022-06
β³ Contract/Temporary
π Senior
π― Recruitment
6 days ago
51 - 200
Lead global marketing strategies for apitegromab, a spinal muscular atrophy treatment at Scholar Rock. Seeking an experienced marketing leader with rare disease expertise.
πΊπΈ United States β Remote
π° $205M Post-IPO Equity on 2022-06
β° Full Time
π Senior
π‘ Marketing
November 23
51 - 200
Oversee pricing, contracting, and government program operations for biopharmaceutical therapies. Manage policies, contracts, and government reporting processes.
πΊπΈ United States β Remote
π° $205M Post-IPO Equity on 2022-06
β° Full Time
π Senior
βοΈ Operations
November 23
51 - 200
Scholar Rock seeks an Associate Director, Clinical Sciences to lead clinical development efforts.
πΊπΈ United States β Remote
π° $205M Post-IPO Equity on 2022-06
β° Full Time
π Senior
π Director